Masaru Matsuda has sold ARQT and made no open-market buys since Jun 2022

Masaru Matsuda is the Senior Vice President, General Counsel, and Corporate Secretary at Arcutis Biotherapeutics, Inc.( He joined Arcutis in January 2022, where he is responsible for all legal and compliance matters for the company, as well as serving as secretary of the board of directors.( Matsuda brings extensive experience in the biopharmaceutical and life sciences sectors, having previously served as senior vice president, general counsel, chief compliance officer, and corporate secretary at Halozyme Therapeutics, Inc.(

Before joining Halozyme, Matsuda spent 18 years at Amgen in positions of increasing responsibility, culminating in his role as vice president of Law for Global Commercial Operations, where he provided strategic commercial legal support to multiple divisions including US Commercial Operations, Medical Affairs, Compliance, Global Value, Access & Policy, Global Marketing, and Biosimilars.( Matsuda holds a Bachelor of Science in Business Administration with a dual emphasis in Corporate Finance and International Finance from the University of Southern California, as well as a Juris Doctorate from University of California, Hastings College of the Law.(

Written by Perplexity from public sources.